Inorganic Nitrates: Qi for Heart Failure With Preserved Ejection Fraction?
暂无分享,去创建一个
[1] R. Townsend,et al. Pharmacokinetics and Pharmacodynamics of Inorganic Nitrate in Heart Failure With Preserved Ejection Fraction , 2017, Circulation research.
[2] Sanjiv J. Shah,et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study , 2017, European heart journal.
[3] D. Kitzman,et al. One Week of Daily Dosing With Beetroot Juice Improves Submaximal Endurance and Blood Pressure in Older Patients With Heart Failure and Preserved Ejection Fraction. , 2016, JACC. Heart failure.
[4] J. Chirinos,et al. The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction , 2016, Current Heart Failure Reports.
[5] Gabriel A. Koepp,et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. , 2015, The New England journal of medicine.
[6] Frederick A. Masoudi,et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction , 2015 .
[7] V. Melenovský,et al. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. , 2015, Journal of the American College of Cardiology.
[8] T. Münzel,et al. Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress , 2015, Antioxidants & redox signaling.
[9] R. Townsend,et al. Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction , 2015, Circulation.
[10] D. Kass,et al. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. , 2014, Circulation research.
[11] J. Mathers,et al. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. , 2013, The Journal of nutrition.
[12] Manesh R. Patel,et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.
[13] D. Kass,et al. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.
[14] M. O'Rourke,et al. Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries , 2005, Heart.
[15] A. Butler,et al. A treatment for cardiovascular dysfunction in a Dunhuang medical manuscript , 2004 .
[16] C. Lang,et al. Vasodilation in black Americans: Attenuated nitric oxide‐mediated responses , 1997, Clinical pharmacology and therapeutics.